Previous Article | Next Article ![]()
Infect. Immun., 05 1996, 1589-1594, Vol 64, No. 5
K Inoue, Y Fujinaga, T Watanabe, T Ohyama, K Takeshi, K Moriishi, H Nakajima, K Inoue and K Oguma
The molecular composition of progenitor toxins produced by a Clostridium
botulinum type A strain (A-NIH) was analyzed. The strain produced three
types of progenitor toxins (19 S, 16 S, and 12 S) as reported previously.
Purified 19 S and 16 S toxins demonstrated the same banding profiles on
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
indicating that they consist of the same protein components. The nontoxic
components of the 19 S and 16 S toxins are a nontoxic non-hemagglutinin
(HA) (molecular mass, 120 kDa) and HA. HA could be fractionated into five
subcomponents with molecular masses of 52, 35, 20, 19, and 15 kDa in the
presence of 2-mercaptoethanol. The molar ratios of neurotoxins, nontoxic
non-HAs, and each HA subcomponent of the 19 S and 16 S toxins showed that
only HA-35 of the 19 S toxin was approximately twice the size of that of
the 16 S toxin, suggesting that the 19 S toxin is a dimer of the 16 S toxin
cross-linked by the 35- kDa subcomponent. The nontoxic non-HA of the 12 S
toxin, but not those of the 19 S and 16 S toxins, demonstrated two bands
with molecular masses of 106 and 13 kDa on SDS-PAGE with or without
2-mercaptoethanol. It was concluded from the N-terminal amino acid
sequences that 106- and 13-kDa proteins were generated by a cleavage of
whole nontoxic non-HA. This may explain why the 12 S and 16 S (and 19 S)
toxins exist in the same culture. We also found that the HA and its 35-kDa
subcomponent exist in a free state in the culture fluid along with three
types of progenitor toxins.
Copyright © 1996, American Society for Microbiology
Molecular composition of Clostridium botulinum type A progenitor toxins
Department of Bacteriology, Okayama University Medical School, Japan.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|